Coya Therapeutics, Inc. (COYA) Misses Q2 EPS by 42c
Tweet
Share
E-mailGet Alerts COYA Hot Sheet
Join SI Premium – FREE
Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.19), $0.42 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $3.43 million.
For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- FDA approves AbbVie's Skyrizi for children with psoriatic disease
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
